NEW YORK (GenomeWeb) – Cancer Genetics on Thursday filed a shelf registration to offer up to $100 million in securities.

In its registration statement filed with the US Securities and Exchange Commission, the firm said that it may from time to time offer common stock, preferred stock, warrants, and overallotment purchase rights and units totaling up to $100 million in aggregate.

Net proceeds are intended for working capital and other general corporate purposes.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.